- Home
- OFG vs DYN Comparison
OFG vs DYN Comparison
Compare OFG & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- DYN
- Stock Information
- Founded
- OFG 1964
- DYN 1984
- Country
- OFG United States
- DYN United States
- Employees
- OFG N/A
- DYN N/A
- Industry
- OFG Major Banks
- DYN Medicinal Chemicals and Botanical Products
- Sector
- OFG Finance
- DYN Health Care
- Exchange
- OFG Nasdaq
- DYN Nasdaq
- Market Cap
- OFG 2.0B
- DYN 1.9B
- IPO Year
- OFG N/A
- DYN 2020
- Fundamental
- Price
- OFG $40.59
- DYN $16.40
- Analyst Decision
- OFG Buy
- DYN Strong Buy
- Analyst Count
- OFG 4
- DYN 14
- Target Price
- OFG $47.50
- DYN $34.93
- AVG Volume (30 Days)
- OFG 236.8K
- DYN 2.7M
- Earning Date
- OFG 10-22-2025
- DYN 11-11-2025
- Dividend Yield
- OFG 2.81%
- DYN N/A
- EPS Growth
- OFG 4.40
- DYN N/A
- EPS
- OFG 4.25
- DYN N/A
- Revenue
- OFG $619,470,000.00
- DYN N/A
- Revenue This Year
- OFG N/A
- DYN N/A
- Revenue Next Year
- OFG $1.89
- DYN N/A
- P/E Ratio
- OFG $10.03
- DYN N/A
- Revenue Growth
- OFG N/A
- DYN N/A
- 52 Week Low
- OFG $33.15
- DYN $6.36
- 52 Week High
- OFG $47.66
- DYN $35.90
- Technical
- Relative Strength Index (RSI)
- OFG 35.37
- DYN 70.29
- Support Level
- OFG $41.45
- DYN $13.73
- Resistance Level
- OFG $43.42
- DYN $15.21
- Average True Range (ATR)
- OFG 1.06
- DYN 0.85
- MACD
- OFG -0.18
- DYN 0.33
- Stochastic Oscillator
- OFG 6.16
- DYN 88.19
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.